ID

20524

Descripción

The Efficacy of CILostazol ON Ischemic Complications After DES Implantation; ODM derived from: https://clinicaltrials.gov/show/NCT00776828

Link

https://clinicaltrials.gov/show/NCT00776828

Palabras clave

Versiones (1)
  1. 1/3/17 1/3/17 -
Subido en

1 de marzo de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Coronary Artery Disease NCT00776828

Inglés

Eligibility Coronary Artery Disease NCT00776828

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject must be at leat 18 years of age
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of cilostazol and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
subject must have significant coronary artery stenosis (>50% by visual estimate)
Descripción

Coronary Stenosis Percentage Visual estimation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0242231
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C0444684
subject must have evidence of myocardial ischemia (e.g., stable, unstable angina, recent infarction, silent ischemia, positive functional study or reversible changes in the electrocardiogram (ecg) consistent with ischemia. in subjects with coronary artery stenosis>75%, evidence of myocardial ischemia does not have to be documented.
Descripción

Myocardial Ischemia; Stable angina; Angina, Unstable; History of myocardial infarction; Silent myocardial ischemia; ECG signs of myocardial ischaemia; Coronary Stenosis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0151744
UMLS CUI [1,2]
C0340288
UMLS CUI [1,3]
C0002965
UMLS CUI [1,4]
C1275835
UMLS CUI [1,5]
C0340291
UMLS CUI [1,6]
C1141959
UMLS CUI [1,7]
C0242231
coronary lesions must be amenable for percutaneous coronary revascularization with drug eluting stents.
Descripción

coronary stenosis amenable for percutaneous coronary revascularization with drug eluting stents

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0242231
UMLS CUI [1,2]
C3526701
UMLS CUI [1,3]
C1262327
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject who undergoes primary percutaneous coronary intervention due to acute st elevation myocardial infarction
Descripción

Emergency percutaneous coronary intervention; Acute ST segment elevation myocardial infarction

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1532297
UMLS CUI [1,2]
C1303258
subject who has contraindication or allergy to anti-platelet agents (aspirin, clopidogrel or cilostazol)
Descripción

hypersensitivity or contraindication to anti-platelet agents (aspirin, clopidogrel or cilostazol)

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1301624
UMLS CUI [1,3]
C2963157
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0004057
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0070166
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0055729
subject who has thrombocytopenia (<120,000/ul)
Descripción

platelet count measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032181
subject who has liver cirrhosis (child class b or c)
Descripción

liver cirrhosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023890
subject who is on the anticoagulation therapy
Descripción

anticoagulation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0449867
subject who has severe congestive heart failure (left ventricular ejection fraction <30%)
Descripción

congestive heart failure, left ventricular ejection fraction

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0428772
Volver a la parte superior de la página

Similar models

Eligibility Coronary Artery Disease NCT00776828

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
subject must be at leat 18 years of age
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of cilostazol and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
boolean
C0021430 (UMLS CUI [1])
Coronary Stenosis Percentage Visual estimation
Item
subject must have significant coronary artery stenosis (>50% by visual estimate)
boolean
C0242231 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0444684 (UMLS CUI [1,3])
Myocardial Ischemia; Stable angina; Angina, Unstable; History of myocardial infarction; Silent myocardial ischemia; ECG signs of myocardial ischaemia; Coronary Stenosis
Item
subject must have evidence of myocardial ischemia (e.g., stable, unstable angina, recent infarction, silent ischemia, positive functional study or reversible changes in the electrocardiogram (ecg) consistent with ischemia. in subjects with coronary artery stenosis>75%, evidence of myocardial ischemia does not have to be documented.
boolean
C0151744 (UMLS CUI [1,1])
C0340288 (UMLS CUI [1,2])
C0002965 (UMLS CUI [1,3])
C1275835 (UMLS CUI [1,4])
C0340291 (UMLS CUI [1,5])
C1141959 (UMLS CUI [1,6])
C0242231 (UMLS CUI [1,7])
coronary stenosis amenable for percutaneous coronary revascularization with drug eluting stents
Item
coronary lesions must be amenable for percutaneous coronary revascularization with drug eluting stents.
boolean
C0242231 (UMLS CUI [1,1])
C3526701 (UMLS CUI [1,2])
C1262327 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Emergency percutaneous coronary intervention; Acute ST segment elevation myocardial infarction
Item
subject who undergoes primary percutaneous coronary intervention due to acute st elevation myocardial infarction
boolean
C1532297 (UMLS CUI [1,1])
C1303258 (UMLS CUI [1,2])
hypersensitivity or contraindication to anti-platelet agents (aspirin, clopidogrel or cilostazol)
Item
subject who has contraindication or allergy to anti-platelet agents (aspirin, clopidogrel or cilostazol)
boolean
C0020517 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C2963157 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0055729 (UMLS CUI [4,2])
platelet count measurement
Item
subject who has thrombocytopenia (<120,000/ul)
boolean
C0032181 (UMLS CUI [1])
liver cirrhosis
Item
subject who has liver cirrhosis (child class b or c)
boolean
C0023890 (UMLS CUI [1])
anticoagulation
Item
subject who is on the anticoagulation therapy
boolean
C0449867 (UMLS CUI [1])
congestive heart failure, left ventricular ejection fraction
Item
subject who has severe congestive heart failure (left ventricular ejection fraction <30%)
boolean
C0018802 (UMLS CUI [1,1])
C0428772 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial